Open Access Open Access  Restricted Access Subscription or Fee Access

Potential pharmacological perspectives for the treatment/prevention of the SARS-COV-2 infection in opioid dependent patients

Maurizio Coppola, MD, Raffaella Mondola, MD

Abstract


-

Full Text:

PDF

References


Chan JF, Kok KH, Zhu Z, et al: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020; 9: 231-236.

American Society of Addiction Medicine: Covid-19 resources 2020. Available at: https://www.asam.org/Quality-Science/covid-19-coronavirus Accessed April 2, 2020.

Adem S, Eyupoglu V, Sarfraz I, et al.: Identification of potent COVID-19 main protease (Mpro) inhibitors from natural polyphenols: An in silico strategy unveils a hope against corona. Preprints. 2020; doi: 10.20944/preprints202003.0333.v1

Loscalzo LM, Wasowski C, Paladini AC, et al.: Opioid receptors are involved in the sedative and antinociceptive effects of hesperidin as well as in its potentiation with benzodiazepines. Eur J Pharmacol. 2008; 580: 306-313.

Selvaraj G, Kaliamurthi S, Thirungnasambandam R, et al.: Antinociceptive effect in mice of thillai flavonoid rutin. Biomed Environ Sci. 2014; 27: 295-299.




DOI: https://doi.org/10.5055/jom.2020.0564

Refbacks

  • There are currently no refbacks.